MedPath

Real-world EValuation of the antithrombotic thErapy And clinicaL outcomes for the patients with Atrial Fibrillation undergoing Percutaneous Coronary Interventio

Not Applicable
Conditions
Atrial Fibrillation Coronary Artery Disease
Registration Number
JPRN-UMIN000022004
Lead Sponsor
Department of Clinical Epidemiology, Hyogo College of Medicine
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Sex
All
Target Recruitment
5000
Inclusion Criteria

Not provided

Exclusion Criteria

Patients who denied participation.

Study & Design

Study Type
Observational
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Composite of death, myocardial infarction, stent thrombosis, stroke, and systemic embolism at 1-year from the index percutaneous coronary intervention.
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath